Did Israelis find THE COVID-19 treatment?

After one week, six critically ill patients in Israel survived. Four of them showed improvement in respiratory parameters.

Israeli-based Pluristem has treated its first American patient suffering from COVID-19 complications under the country’s compassionate use program.

The news comes days after a report by the company showed that six critically ill coronavirus patients in Israel who are considered high-risk for mortality were treated with Pluristem’s placenta-based cell-therapy product and survived, according to preliminary data provided by the Haifa-based company.